Imago BioSciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Imago BioSciences generated cash of -$39,763,000, which is less than the previous year. Cash used in financing activities reached the amount of $160,992,000 last year. Net change in cash is therefore -$8,040,000.
Cash Flow
| 2019 | -10.00M | -2.72M | 16.43M |
|---|---|---|---|
| 2020 | -16.94M | -74.34M | 105.58M |
| 2021 | -39.76M | -129.26M | 160.99M |
IMGO Cash Flow Statement (2019 – 2021)
| 2021 | 2020 | 2019 | |
|---|---|---|---|
Cash at beginning of period | 19.26M | 4.96M | 1.25M |
Operating activities | |||
Net income | -42.31M | -17.83M | -10.90M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 6K | 1K | 0 |
Stock-based compensation expense | 2.22M | 426K | 318K |
| Deferred income tax benefit | 2.22M | 426K | 318K |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 |
Accounts payable | 2.06M | 8K | 586K |
Cash generated by operating activities | -39.76M | -16.94M | -10.00M |
Investing activities | |||
Purchases Of Investments | -208.42M | -81.08M | -2.72M |
Investments In Property Plant And Equipment | 0 | -9K | 0 |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | -129.26M | -74.34M | -2.72M |
Financing activities | |||
Common Stock Issued | 163.74M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 |
Cash used in financing activities | 160.99M | 105.58M | 16.43M |
Net Change In Cash | -8.04M | 14.30M | 3.70M |
Cash at end of period | 11.22M | 19.26M | 4.96M |
| Data source |